Title : Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

Pub. Date : 2017

PMID : 28182722






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Improvements in glycemic control were statistically significantly associated with the tested DPP-4 inhibitors in the high HGI group (-2.4, -1.4, -1.2 and -2.2% [-26.2, -15.3, -13.1 and -24.0 mmol/mol] for vildagliptin, linagliptin, saxagliptin and sitagliptin, respectively) but not in the low HGI group. Vildagliptin dipeptidyl peptidase 4 Homo sapiens